Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Smriti Khanna"'
Autor:
Vikramjit S. Kanwar, Poonam Bagai, Anupama Borker, Veronique Dinand, Roop Gursahani, Krutika Kurhade, Manas Kalra, Smriti Khanna, Manjusha Nair, Amita Mahajan, Gayatri Palat, Raghwesh Ranjan, Santanu Sen, Lakshmi Shobhavat
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 9, Iss 1, Pp 18-23 (2024)
In the last four decades, survival in childhood cancer in India has improved significantly, however we increasingly face the question that has challenged providers in high-income countries: when care becomes futile and merely prolongs suffering, how
Externí odkaz:
https://doaj.org/article/a7b0e55e6b9344a6a5c9a3d1cd7e6cfd
Publikováno v:
IP Journal of Diagnostic Pathology and Oncology. 7:126-129
The present case report comprises of an unusual presentation of oral malignant melanoma which occurred in the furcation area of maxillary right first molar. A clinician may not suspect a malignant neoplasm and the histopathological examination of the
Autor:
Priyanka, Chauhan, Anshul, Gupta, M, Gopinathan, Sanjeev, Akanksha, Garg, Smriti, Khanna, Ruchi, Gupta, Khaliqur, Rahman, Dinesh, Chandra, Manish Kumar, Singh, Soniya, Nityanand
Publikováno v:
Annals of Hematology. 101:1261-1273
The outcome of acute myeloid leukemia (AML) in low-middle-income countries (LMIC) is dismal due to delayed clinical presentation and infection-related complications. We aimed to analyze the outcome of patients with AML and the factors associated with
Autor:
SMRITI KHANNA, Dr.ARCHANA MAHAMUNI
The most promising and enthralling technology of age is the Electric Vehicle (EV) technology. It has been neutralizing the growing menace of carbon emission and reducing the dependence on fossil fuel and excessive energy consumption. The EV technolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09c8849f0244bafe0509de8b328ee3bf
Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S. A. S. Nagar-160 062, Punjab, India Department of Pharmacy, Birla Institute of Technology and Science-Pilani (BITS), Pilani Campus, V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d0907f00682d6fe59ae737a9998411a
Autor:
Anagha Damre, S. Sarveswari, Pradip K. Gadekar, Smriti Khanna, Julie Bose, Abhijit Roychowdhury, Ganesh Devidas Urunkar, Rajiv Sharma
Publikováno v:
Bioorganic Chemistry. 115:105151
Herein we describe the design, synthesis and anticancer evaluation of a series of 2,3-dihydroimidazo[2,1-b]thiazoles as dual kinase inhibitors of IGF1R and EGFR. A series of saturated dihydroimidazo[2,1-b] thiazoles were synthesized to understand the
Autor:
Jayita Deodhar, Veronique Dinand, Pradnya Talawadekar, Prakash Fernandes, Mary Ann Muckaden, Smriti Khanna
Publikováno v:
Indian Journal of Palliative Care
Indian Journal of Palliative Care, Vol 26, Iss 5, Pp 17-20 (2020)
Indian Journal of Palliative Care, Vol 26, Iss 5, Pp 17-20 (2020)
Introduction: The COVID 19 pandemic has created difficulties for children registered under Children's Palliative Care in Mumbai. 2 hospitals who have started Services last year would like to share their experiences on difficulties faced by Children a
Autor:
Smriti Khanna, Chandrika B-Rao, Kishori Sharan Singh, Abhijit Roychowdhury, Julie Bose, Rajiv Sharma, Sambhaji V. Patil, Anagha Damre, Neeta Dixit, Sambhaji Chavan, Valmik Sopan Aware, Sonal M Manohar, Nitin D. Gaikwad
Publikováno v:
European Journal of Medicinal Chemistry. 92:246-256
A series of novel 2-amino-4-pyrazolecyclopentylpyrimidines have been prepared and evaluated as IGF-1R tyrosin kinase inhibitors. The in vitro activity was found to depend strongly on the substitution pattern in the 2- amino ring, 4-pyrazolo moieties
Autor:
Usha Ghosh, Smriti Khanna, Asha Kulkarni-Almeida, Ankita Srivastava, Komal Bajaj, Chandrika B-Rao, Prashant Tannu, Ashish P. Keche, Kumar V.S. Nemmani, Pranay Shah, Sandeep Burudkar, Rajiv Sharma, Yogesh Suresh Ahire, H. Sivaramakrishnan, Amol Dixit, Anagha Damre, Nitin J. Deshmukh
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:834-838
We report our attempts at improving the oral efficacy of low-nanomolar inhibitors of xanthine oxidase from isocytosine series through chemical modifications. Our lead compound had earlier shown good in vivo efficacy when administered intraperitoneall
Autor:
Rajiv Sharma, Smriti Khanna, Umakant Ashok Bahirat, Asha Kulkarni-Almeida, Pranay Shah, Amol Dixit, Kamlesh V. Katkar, Kumar V.S. Nemmani, Ashish P. Keche, H. Sivaramakrishnan, Vaidehi Korde, Chandrika B-Rao, Ankita Srivastava, Nitin J. Deshmukh, Manoja K. Brahma, Lalit S. Doshi, Usha Ghosh
Publikováno v:
Bioorganic & Medicinal Chemistry. 20:2930-2939
In recent years, xanthine oxidase has emerged as an important target not only for gout but also for cardiovascular and metabolic disorders involving hyperuricemia. Contrary to popular belief, recent clinical trials with uricosurics have demonstrated